Menu
Back to User profile » Dr Xinting Sang
Papers published by Dr Xinting Sang:
Metabolic Tumor Volume Measured by 18F-FDG PET/CT is Associated with the Survival of Unresectable Hepatocellular Carcinoma Treated with PD-1/PD-L1 Inhibitors Plus Molecular Targeted Agents
Wang X, Yang X, Wang J, Dong C, Ding J, Wu M, Wang Y, Ding H, Zhang H, Sang X, Zhao H, Huo L
Journal of Hepatocellular Carcinoma 2023, 10:587-598
Published Date: 8 April 2023
In situ Detecting Lipids as Potential Biomarkers for the Diagnosis and Prognosis of Intrahepatic Cholangiocarcinoma
Li J, Chen Q, Guo L, Li J, Jin B, Wu X, Shi Y, Xu H, Zheng Y, Wang Y, Du S, Li Z, Lu X, Sang X, Mao Y
Cancer Management and Research 2022, 14:2903-2912
Published Date: 26 September 2022
The Prognostic Value of Systemic Inflammation Response Index in Cholangiocarcinoma Patients
Jin B, Hu W, Su S, Xu H, Lu X, Sang X, Yang H, Mao Y, Du S
Cancer Management and Research 2021, 13:6263-6277
Published Date: 10 August 2021
Preoperative Immune Prognostic Index Can Predict the Clinical Outcomes of Patients with Gallbladder Cancer: Single-Center Experience
Sun L, Wang D, Zhang M, Jin Y, Jin B, Xu H, Du S, Xu Y, Zhao H, Lu X, Sang X, Zhong S, Yang H, Mao Y
Cancer Management and Research 2020, 12:12137-12150
Published Date: 25 November 2020
Development and Verification of the Hypoxia-Related and Immune-Associated Prognosis Signature for Hepatocellular Carcinoma
Hu B, Yang XB, Sang XT
Journal of Hepatocellular Carcinoma 2020, 7:315-330
Published Date: 11 November 2020
Prognostic Nomogram That Predicts Overall Survival of Patients with Distal Cholangiocarcinoma After Pancreatoduodenectomy
Chen Q, Li J, Jin B, Wu X, Shi Y, Xu H, Zheng Y, Wang Y, Du S, Lu X, Sang X, Mao Y
Cancer Management and Research 2020, 12:10303-10310
Published Date: 20 October 2020
Prognostic Significance of the Preoperative Lymphocyte to Monocyte Ratio in Patients with Gallbladder Carcinoma
Xu W, Wu X, Wang X, Yu S, Xu G, Xiong J, Zhang J, Sang X, Zheng Y, Liu W
Cancer Management and Research 2020, 12:3271-3283
Published Date: 11 May 2020
Preoperative Bilirubin-Adjusted Carbohydrate Antigen 19-9 as a Prognostic Factor for Extrahepatic Cholangiocarcinoma Patients at a Single Center
Li J, Chen Q, Jin B, Shi Y, Wu X, Xu H, Zheng Y, Wang Y, Du S, Lu X, Mao Y, Sang X
Cancer Management and Research 2020, 12:411-417
Published Date: 20 January 2020
Preoperative neutrophil–lymphocyte and platelet–lymphocyte ratios as independent predictors of T stages in hilar cholangiocarcinoma
Huang H, Wan X, Bai Y, Bian J, Xiong J, Xu Y, Sang X, Zhao H
Cancer Management and Research 2019, 11:5157-5162
Published Date: 4 June 2019